The dose–response relationship between Ang IV and the parasite erythrocytic cycle showed that the peptide inhibited infection of new erythrocytes by 70% with the maximum effect observed at lower doses (10−12 M) (Fig. 6A). The gene discussed is AGT; the disease is infection.